Detection of blaSHV, blaTEM and bla CTX-M among ‎Urinary Tract Infection Escherichia coli isolates by Ali, Mun,im Radwan et al.




Detection of blaSHV, blaTEM and bla CTX-M among 
Urinary Tract Infection Escherichia coli isolates 
Mun
,
im Radwan Ali  Maha Mekhlef Kahdim 
Department of biology -Collage of science- Al-Mustansiryah University. 
Shahbaa Hamid Majeed 
Departme of science -Collage of basic education- Al-Mustansiryah University. 
mnumbio77@yahoo.com    Maha1979.mk@gmail.com    Shalubidi@yahoo.com  
Abstract 
    One hundred fifty urine samples were collected from urinary tract infection patients. We obtained 40 
isolates of Escherichia coli among these clinical samples. A proportion of UTI in females 93 (62%) is 
higher than that in males 57 (38%). All locally isolates are multi-resistant, the highest rate of resistance 
was seen with Amoxicillin/clavulanic acid, and Cloxacillin. The results showed high percentage 14(35%) 
of class C among locally isolates , while only 4(10%) are able to produce Class A ESβL , on the other 
hand  (7/40) and (8/40) were ESβL neither Class A nor Class C Present and ESβL absent respectively , 
while among the 40 isolates only 7 isolates were Non-Typable. Three types of  β-lactamases include 
ESβLs genes (blaSHV, blaTEM, blaCTX-M) by the use of uniplex PCR assay. The blaSHV was detected in 1 
isolates (2.5%) of the UPEC isolates, while for the blaTEM gene the result showed that in 27 detected 
isolates (67.5%), there is 23 isolates (57.5%) which indicates the prevalence of  blaCTX-M gene. The results 
showed the Co-existence  of blaTEM, blaCTX-M in 30% of isolates, while one isolate  blaSHV, blaTEM, blaCTX-M  
in their genome component. 
Keywords: blaSHV, blaTEM and blaCTX-M, PCR assay,Urinary tract infection,    E.coli. 
ةصلاخلا 
 تعمج150  دوجو ةساردلا ترهظا دقو، ةيلوبلا يراجملا باهتلاب نيباصم ىضرم نمراردا ةنيع40  ايرتكبل دوعت ةلزع
Esherichia coli  ذا لاجرلا قوفت ءاسنلا دنع تناك ةيلوبلا يراجملا باهتلاب ةباصلاا تلااح نا تدجو دقو. ةيمكلا تانيعلا عومجم نم
(ءاسنلا ىدل تغمب62)%93 اك امنيب(لاجرلا دنعاهتبسن تن38)%57  ةمواقم تاذ ةساردلا ديق ةيمحملا ةيريتكبلا تلازعلا عيمج ترهظا،
 ةبسن ىمعا جئاتنلا تنيب دقو،نيمساسكومكلاو كنولويفلاكلا ضماح، نيمسكوملاا داضمل ةمواقم ةبسن ىمعا تناكو ةيويحلا تاداضممل ةيلاع
 و تاميزنا كمتمت يتلا ةيمحملا تلازعمل ةمواقممل فنص فيطلا ةعساC ( ةبسنبو35)%14 ( تناك امنيب10)%4  ةعساولا تاميزنلا ةجتنم
 فنص فيطلاA ( تناك ىرخا ةهج نمو ،40/7(و ةلزع )40/8فنص نم لكل فيطلا ةعساو تاميزنلا ةجتنم ريغ تلازعلا نم )A   و
C  فيطلا ةعساو تاميزنلا ةرفشملا تانيجلا ةسارد مت دقو. يلاوتلا ىمعblaSHV   وbla TEM     وbla CTX-M      يفعاضتلا لعافتلا ةطساوب
( ةبسنبو ةدحاو ةلزع نا جئاتنلا ترهظا دقو، اندلا ةمسمسل2.5 نيج كممت تناك)%blaSHV  تناك امنيب27 ( ةبسنبو ةلزع67.5 )%
 نيج كممتblaTEM   و23 ( ةبسنب ةلزع57.5 نيج لمحت )bla CTX-M      نا جئاتنلا ترهظاو30 نم %  ةجتنم تناك تلازعلا
 تاميزنا نم لكلbla TEM      وbla CTX-M    كممت تناك ةدحاو ةلزع طقف امنيب3 يهو ةرفشم تانيج blaSHV   وbla TEM    
 وbla CTX-M . 
:ةيحاتفملا تاممكلا ،يلاوك ايشيرشاةيلوبلا يراجملا باهتلا ،blaSHV , blaTEM and blaCTX-M , PCR assay. 
 
Introduction 
The β-lactams, such as penicillins, cephalosporins and carbapenems are the most 
commonly used antibiotics for treatment of nosocomial infections (Wright, 2000).  
Resistance to broad spectrum beta-lactams, mediated by extended spectrum beta-
lactamase (ESBL), AmpC beta-lactamases (AmpC), and metallo-beta-lactamase (MBL) 
enzymes are an increasing problem worldwide , Presence of the latter two enzymes in 
clinical infections can result in treatment failure if one of the second- or third-generation 
cephalosporins is used (Singhal et al.,2005). Extended-spectrum _-lactamases (ESBLs) 




were first described in the 1980s and they have been detected in Klebsiella species, and 
later in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens and other 
gram-negative bacilli (Kiratin et al., 2008). During the last century, bacteria has evolved 
the mechanisms to resist against antibiotics. Resistance to β-lactam antibiotics may be 
occurred as a result of permeability barriers, efflux pumps, altered penicillin binding 
proteins, AmpC-type β- lactamases and other products of β-lactamases (Conceição et al., 
2005). Release of β-lactams, gram negative bacilli that harbored mutated versions of the 
potent TEM and SHV enzymes were detected. These and other newly detected β- 
lactamases (for example CTX-M) hydrolyze β-lactam antibiotics containing the 
oxymino side-chain (Paterson et al., 2004). CTX-M preferentially hydrolyze cefotaxime 
and based on the changes in amino acids sequences identities is divided into five groups. 
In the present study, we detect ESBLs among the E. coli isolates cultured from UTI-
patients. Morever, the determination of susceptibility patterns against third-generation 
cephalosporins and identify the types of extendedspectrum beta-lactamases (ESBL) 
blaSHV, blaTEM and bla CTX-M, beta-lactamase genes in ESBL producing isolates 
were also targeted. In an attempt to make detection of these markers of drug resistance 
part of the daily activities of a diagnostic microbiology laboratory, to reduce the 
suffering of patients as a result of taking the treatments are inappropriate  
Material and Methods 
Collection of Urine Samples: One handrad fifty urine samples were collected during 
June to November 2011 from (1 year to 73 years) for isolation of E. coli. A total of 40 
isolates of E. coli were studied and taken from UTI patients who were studied clinically 
suspected to suffer from urinary tract infection according to (Chessbrough ,1993) 
Isolation and Identification of Escherichia coli: For isolation of bacteria urine 
samples were first inoculated into MacConkey agar and incubated at 37°C for 24 h, after 
which a loopful was spread on to  plates of Eosin Methylene Blue and further  incubated 
at 37°C for 24 h. Isolates were  further purified by picking discrete  colonies (green 
metallic sheen) and sub culturing onto fresh plates of EMB and further incubating for 18 
to 24 h at 37°C .After incubation, 1 to 2 discrete colonies were inoculated into the 
presumptive diagnostic medium sulfide indole motility medium (SIM) and incubated at 
35°C for 24 h. Further characterization of isolates was carried out using the IMVIC test. 
Isolates that were indole positive ,hydrogen sulfide negative, non-motile, as well as 
methyl red, Vogues – Proskauer and citrate utilization tests were identified as E. coli, 
fermentation of lactose, ability to produce indole, reaction on triple sugar iron (TSI) 
medium, hemolysis on blood agar, citrate utilization and motility of organism (Atlas et 
al., 1995).The identifications were confirmed by the API 20E test system (Bio- 
Merieux). 
Detection of Susceptibility to Antibacterial Agents: Susceptibility of all the 
isolates to different antibiotics was determined by the disc diffusion method as 
recommended by the Clinical and Laboratory Standards Institute (CLSI). The antibiotic 
discs used in this study were Amoxicillin/clavulanic acid, Cloxacillin , Cefotaxim, 
CoTrimoxizole (Trimethoprim-Sulfamethaxazole) , Naldixic acid , Nitrofurantoin, 




Ciprofloxacin, Ofloxacin, Norfloxacin and Pifloxacin  .Each antibiotic concentration 
was applied on the surface of Muller -Hinton agar plates inoculated with E. coli isolates 
and incubated at 37°C for 24 h. (Tankhiwale et al., 2004). 
Detection of the expression of AmpC gene and ESβLs: In order to simultaneously 
detect ESβL and AmpC, a modified double disk approximation method (MDDM), was 
devised. A 0.5 McFarland of test isolate was swabbed on Mueller Hinton Agar (Difco) 
plates and disk of Cefotaxime (30 µg) and Ceftazidime (30 µg) were placed adjacent to 
Clavulanic acid (10 µg) and Cefoxitin (30 µg) disk at a distance of 20 mm from each 
other. After incubation, an enhanced zone of inhibition between any of the disk 
Ceftazidime and Clavulanic acid were interpreted as presumptive evidence for the 
presence of ESβL. Isolates showing blunting of Ceftazidime zone of inhibition adjacent 
to Cefoxitin disk or showing reduced susceptibility to either of the above test drugs 
(Ceftazidime) and Cefoxitin were considered as "screen positive" and were selected for 
detection of AmpC β-lactamases. (20). The following classification was used.  
(Sinha et al., 2008) 
: 
(i) Potentiation of the inhibition zone (IZ) of any one of Cefpodoxime, Ceftazidime, 
Ceftriaxone, or Aztreonam when combined with Clavulanic acid. 
(ii) Susceptibility (S) to Cefoxitin. 
(iii) S or resistance (R) to any one of Ceftazidime, Ceftriaxone, or Aztreonam. 
: 
(i) Potentiation of the IZ of any one of Cefpodoxime,Ceftazidime, Ceftriaxone, or 
Aztreonam when combined with Clavulanic acid. 
)ii) R or intermediate (I) to cefoxitin. 
)iii) S or R to any one of Ceftazidime, Ceftriaxone, or Aztreonam. 
: 
)i) No potentiation with Clavulanic acid. 
)ii) R or I to Cefoxitin. 
)iii) R to any one of Ceftazidime, Ceftriaxone, or Aztreonam. 
: 
)i) No potentiation with Clavulanic acid. 
)ii) S to Cefoxitin. 
)iii) R to any one of Ceftazidime, Ceftriaxone, or Aztreonam. 
 
)i) No potentiation with Clavulanic acid. 
)ii) S or R to Cefoxitin. 
)iii) S to all of Ceftazidime, Ceftriaxone, or Aztreonam.All the isolates were 
simultaneously subjected to AmpC disc test for AmpC βL detection 
Preparation of bacterial DNA: The DNA to be amplified was extracted from whole 
organisms by boiling method. The bacteria were harvested from 1.5 ml of an overnight 
Luria-Bertani broth culture, suspended in sterile distilled water, and incubated at 95 C◦ 
for 10 min. Following centrifugation of the lysate, the supernatant was stored at -20 C◦ 
as a template DNA stock (Farshad et al ., 2010) . 
Uniplex PCR amplification procedure: Three primer sets were used to amplify an 
internal region of the blaTEM, blaSHV and bla CTX-M genes according to 
 (Kalantar  et al., 2010) . The primers sequences were previously reported by and 
obtained from Alpha DNA company (USA). Amplification was performed in a thermal 




cycler (Eppendorf, Germany). Using the following primers for blaTEM 
 F(5΄-GAGTATTCAACATTTCCGTGTC-3΄).blaTEM R (5΄- 
TAATCAGAGGCACCTATCTC-3΄); the reactions mixtures included an initial 
denaturation at 94°C for 5 min consisted of 35 cycles of 94 ºC for 30 seconds , specific 
annealing temperature 48 C◦ for 60 seconds and  72 ºC for 5 min 30 seconds, and a final 
extension at 72 ºC for 10 min. while blaSHV F(5΄- AAGATCCACTATCGCCAGCAG- 
3΄), blaSHV R(5΄- ATTCAGTTCCGTTTCCCAGCGG - 3΄); the reactions mixtures 
included an initial denaturation at 94°C for 5 min consisted of 35 cycles of 94 ºC for 60 
seconds , specific annealing temperature 59C◦ for 60 seconds and  72 ºC for 60 seconds, 
and a final extension at 72 ºC for 10 min. for CTX-M F(5΄- CGCTTTGCGATGTGAAG- 
3΄), CTX-M R(5΄- ACCGCGATATCGTTGGT - 3΄) gene the reactions mixtures included 
an initial denaturation at 94°C for 5 min consisted of 35 cycles of 94 ºC for 60 seconds , 
specific annealing temperature 55C◦ for 60 seconds and  72 ºC for 60 seconds and a final 
extension at 72 ºC for 10 min in Thermal Cycler. The detection PCR products was 
performed on 0.8 to 1% agarose gels by electrophoresis and visualized under UV light. 
Results and Discusion 
Isolation of Escherichia coli 
    One hundred fifty urine samples were collected from urinary tract infection patients. 
We obtained 40 isolates of Escherichia coli among these clinical samples. These were 
compatible with Abass et al (2014) who found that E.coli is the major causative agent in 
human UTIs, one of the most common bacterial infections. Virtually any bacteria can 
occasionally cause an UTI but irrespective of sex, age and geography E. coli is the 
dominating pathogen (Naber.,2008) and is the causative agent in 90% of the cases in 
younger patients with uncomplicated UTI (Kahlmeter.,2003). In older women the 
etiological spectrum is more complex (Molander et al.,2000) . 
Table 3-1: Demographic data of Escherichia coli UTI patients 
Variable Data 
 
Age of patients 1year -73 years 
Sex of patients 
Female : male 
 
93:57 
Clinical case in  adult women UTI    
Clinical case in girls UTI  
Clinical case in  men  UTI   





This table indicates that, a higher proportion of UTI in females 93 (62%) than that 
in males 57 (38%). This is understandable due to the anatomy and is a consistent trend 
worldwide .The study is in agreement with (Jadhav et al., 2011).                                                        
UTIs are common infections and the increased antimicrobial resistance hinder their 
treatment. The most commonly used antibacterial drugs in the treatment of UTI are 
trimethoprim-sulfamethoxazole, cephalosporins, semi-synthetic penicillins with or 
without beta-lactamase inhibitors and quinolones (Chung et al., 2010).                                                                      
It has been observed that all isolates are multi-resistant , the highest rate of 
resistance is seen with Amoxicillin/clavulanic acid, and Cloxacillin and are moderately 




resistant to Cefotaxim, CoTrimoxizole (Trimethoprim-Sulfamethaxazole) and Naldixic 
acid whereas some isolates have shown lowest rates of resistance to Nitrofurantoin, 
Ciprofloxacin, Ofloxacin, Norfloxacin and Pifloxacin . 
Phenotypic methods are not able to distinguish between the specific enzymes 
responsible for ESβL production (SHV, TEM, and CTX-M types). Several research or 
reference laboratories use genotypic methods for the identification of the specific gene 
responsible for the production of the ESβL, which have the additional ability to detect 
low-level resistance (i.e, can be missed by phenotypic methods). Furthermore, molecular 
assays also have the potential to be done directly on clinical specimens without culturing 
the bacteria, with subsequent reduction of detection time (Farkosh, 2007).Unfortunately, 
extensive use of antibiotics is the cause of resistance phenomena, and treatment of these 
infections especially nosocomial infections faces a serious problem. ESβLs are enzymes 
that confer resistance to third generation cephalosporins and monolactams. A large 
number of plasmid-transferable ESβLs capable of inactivating extended-spectrum 
cephalosporins have been discovered (Bradford, 2001). 
The results showed (Table 2) high percentage 14(35%) of class C among locally 
isolates, while only 4(10%) are able to produce Class A ESβL , on the other hand  (7/40) 
and (8/40) were ESβL niether Class A nor Class C Present and ESβL is absent 
respectively , while among 40 isolates only 7 isolates were Non-Typable.  





Class A or Class 
C Present 
Class C  
ESβL Present 
Class A & 





7(17.5%) 8(20%) 7(17.5%) 14(35%) - 4(10%) 
 
    In this study, total of 40 UPEC isolates were recovered during the study period to use 
for detecting three types of  β-lactamases including ESβLs genes 
 (blaSHV, blaTEM, blaCTX-M) by the use of uniplex PCR assay. The genotyping results of 
ESβLs producing isolates obtained by uniplex PCR amplification of SHV, CTX-M,TEM  
is shown in table (2). 
Table 3:The β-lacatamses genes and Percentage pattern of E.coli from pregnant woman: 
ESβLs β-lacatamses genes Number of positive 
isolates (N40) 
Percentage of positive 
isolates (N40) 
SHV 1 2.5% 
CTX-M 23 57.5% 
TEM 27 67.5% 
CTX-M &TEM 12 30% 
SHV, CTX-M &TEM 1 2.5% 





    In the current study the result showed that the blaSHV was detected in 1 isolates (2.5%) 
of the UPEC isolates using boiling method. The result of blaSHV gene is not identical 
with Pakzad et al.(2011)  where the findings revealed the emergence of a high 
proportion of the blaSHV gene that was 95.2% of E.coli isolates. while Pongpech et al. 
(2008) reported that the frequency of blaSHV gene was 8% of the confirmed ESBL 
producing E. coli isolates  
      While for the blaTEM gene the result showed that it was detected in 27 isolates 
(67.5%) of the UPEC isolates. This result of the current study  is in line with the result 
of Almohana (2013)  that showed that the  blaTEM gene which was (57.1%) of E.coli 
isolates. The variation in our study results compared with others about prevalence rate of 
blaSHV and blaTEM  may be raised from different reasons such as the difference in type 
and volume of consumption of antibiotics and difference in time during which the 
isolates were collected (Al-Agamy et al., 2009).   
       The current results showed the prevalence of  blaCTX-M gene (amplified size 550bp) 
also which was chosen for the genotypic detection for  ESβL was also present in the 23 
isolates (57.5%). The results of blaCTX-M gene of the current study which are similar with 
the results of Chaudhuri et al. (2011) also showed a total of 63.5% of ESBL producers 
isolates carried blaCTX-M. The blaCTX-M has detected  the most common type of blaCTX-M 
from Asia, Europe , North and South America among multidrug-resistant E .coli 
(Feizabadi et al ., 2010).    
 
Figure1: Agaros gel electrophoresis(1% agarose, 7 v/cm
2 
)  and Ethidium bromide 
staining to detect A: blaSHV gene size product (band 200bp); B: to detect blaTEM gene size 
product (band 800bp); C: to detect blaCTX-M gene size product (band 550bp) by using 
template DNA prepared by  boiling method. Right Lane , molecular size DNA ladder 
(100 bp DNA Ladder); Left lanes DNAs isolated from E. coli sample showed Positive 
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